glp-1 agonists: PDB-101: Molecule of the Month: Receptor Agonists GLP- 1 Agonist Therapy Center
Description
Physicians on Sermo share experiences with GLP-1 weight loss drugs and risks
2023 2 Minute Medicine, Inc
Research on the experimental drug petrelintide suggests it is much less likely to cause nausea and vomiting than GLP-1 drugs, but the pace of weight loss is more moderate.
Wondering about GLP-1 dosing approaches
The product is formulated to support healthy weight management
